Diabetes PubMed

  • Increase font size
  • Default font size
  • Decrease font size
Home Complications Short Term Hypoglycemia Confirmation of Hypoglycemia in the 'Dead-in-Bed' Syndrome as Captured by a Retrospective Continuous Glucose Monitoring System

Confirmation of Hypoglycemia in the 'Dead-in-Bed' Syndrome as Captured by a Retrospective Continuous Glucose Monitoring System

Endocr Pract. 2009 Oct 15:1-13.

Tanenberg RJ, Newton CA, Drake AJ.

Objective: The "dead-in-bed" syndrome accounts for approximately 6% of the mortality in patients with type 1 diabetes under the age of forty. Although theories explaining the syndrome involve hypoglycemia, proof of its presence is lacking since immediate postmortem glucose measurements are rarely obtained.Methods: We describe a case of a 23 year old man with a history of type 1 diabetes treated with an insulin pump, who had recurrent severe hypoglycemia. To better understand and eliminate these episodes the patient was placed on a retrospective continuous glucose monitoring system (CGMS). He was found dead in his undisturbed bed 20 hours later. The insulin pump and CGMS were both downloaded postmortem.Results: Postmortem download of the data in the CGMS demonstrated glucose levels below 30 mg/dL around the time of his death with only a minimal counterregulatory response. This corresponded to a post mortem vitreous glucose of 25 mg/dL.Conclusions: To our knowledge, this is the first documentation of hypoglycemia at the time of death in the "dead-in-bed" syndrome. This report should raise the awareness of physicians to the potentially lethal effects of hypoglycemia and provide justification of efforts directed at avoiding nocturnal hypoglycemia.

PMID: 19833577

 

Bookmark and Share

Popular Diabetes PubMed Citations

Newsflash

Millions unite for diabetes awareness on World Diabetes Day 2010
Starting today, people from all corners of the world are uniting together for three days of celebration to put diabetes firmly in the public spotlight. World Diabetes Day is the best opportunity there is to draw attention to the silent killer that is diabetes.
 
Bristol-Myers Squibb Foundation Launches $100 Million Initiative
The Bristol-Myers Squibb Foundation announced Together on Diabetes®: Communities Uniting to Meet America's Diabetes Challenge, a 5-year, $100 million initiative to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor's office - in their homes and communities - and for the course of their disease.
 
New global survey reveals more than one in three patients fail to take insulin as prescribed
More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77% of physicians estimate that in reality this number could be as high as six doses*, according to the Global Attitudes of Patients and Physicians in Insulin Therapy (GAPPTM) survey, released today by Novo Nordisk.
 

Facebook Page Twitter Subscribe to Latest Diabetes PubMed facts... by Email RSS

Subscribe

Get Diabetes PubMed facts delivered by email. Enter your email address:


Delivered by FeedBurner

Who's Online

We have 2 guests online

Sponsored Links

PharmaNews.eu
PharmaNews.eu - the dynamic European pharmaceutical news engine.
www.pharmanews.eu

Advertise here